ABRYNTA Trademark

Trademark Overview

On Thursday, April 28, 2011, a trademark application was filed for ABRYNTA with the United States Patent and Trademark Office. The USPTO has given the ABRYNTA trademark a serial number of 85307100. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 27, 2020. This trademark is owned by Pfizer Inc.. The ABRYNTA trademark is filed in the Pharmaceutical Products category with the following description:

vaccines for human use
abrynta

General Information

Serial Number85307100
Word MarkABRYNTA
Filing DateThursday, April 28, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 27, 2020
Registration Number4388555
Registration DateTuesday, August 20, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2011

Trademark Statements

Goods and Servicesvaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 27, 2020
Primary Code005
First Use Anywhere DateTuesday, April 30, 2013
First Use In Commerce DateTuesday, April 30, 2013

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, March 27, 2020CANCELLED SEC. 8 (6-YR)
Monday, August 20, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 20, 2013REGISTERED-PRINCIPAL REGISTER
Thursday, July 18, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, July 17, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, July 17, 2013ASSIGNED TO LIE
Friday, June 28, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 28, 2013STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 19, 2013USE AMENDMENT FILED
Wednesday, June 19, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, May 14, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 13, 2013EXTENSION 3 GRANTED
Tuesday, April 30, 2013EXTENSION 3 FILED
Tuesday, April 30, 2013TEAS EXTENSION RECEIVED
Wednesday, November 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 13, 2012EXTENSION 2 GRANTED
Thursday, November 8, 2012EXTENSION 2 FILED
Thursday, November 8, 2012TEAS EXTENSION RECEIVED
Saturday, May 26, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 25, 2012EXTENSION 1 GRANTED
Friday, May 4, 2012EXTENSION 1 FILED
Friday, May 25, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 4, 2012TEAS EXTENSION RECEIVED
Tuesday, November 15, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 20, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2011PUBLISHED FOR OPPOSITION
Monday, August 15, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 8, 2011ASSIGNED TO EXAMINER
Tuesday, May 3, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 2, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

abrynta human vaccines